Structures by: Nicoló F.
Total: 51
<i>N</i>,<i>N</i>'-Bis(4-methylphenyl)ethanedithioamide
C32H32N4S4
Acta Crystallographica Section E (2015) 71, 2 o67
a=33.9423(7)Å b=11.3880(2)Å c=7.8049(2)Å
α=90° β=99.4390(10)° γ=90°
(8aR,SS)-Dimethyl 3,5,6,7,8,8a-hexahydro-4-{[(1S)-exo-2-hydroxy-7,7- dimethylbicyclo[2.2.1]heptan-1-yl]methylsulfinyl}-1,2-naphthalenedicarboxylate
C24H34O6S
Acta Crystallographica Section E (2004) 60, 5 o733-o735
a=6.8037(6)Å b=7.7391(8)Å c=11.9131(9)Å
α=84.539(8)° β=74.277(6)° γ=78.323(7)°
R-1,c-2,c-3,t-4,5-pentachloro-6-phenyltetralin
C16H11Cl5
Acta Crystallographica Section E (2001) 57, 11 o1045-o1046
a=13.321(3)Å b=9.101(2)Å c=14.279(3)Å
α=90.00° β=112.77(3)° γ=90.00°
9-(4-Methyl-benzylidene)-4,8-diphenyl-6-p-tolyl-2-oxa- 3,7-diazaspiro[4.4]nona-3,7-dien-1-one
C33H26N2O2
Acta Crystallographica Section E (2001) 57, 5 o396-o398
a=10.909(3)Å b=18.502(7)Å c=13.092(4)Å
α=90.00° β=97.143(12)° γ=90.00°
9-(2-Methoxy-benzylidene)-6-(2-methoxy-phenyl)-4,8-diphenyl-2-oxa- 3,7-diazaspiro[4.4]nona-3,7-dien-1-one
C33H26N2O4
Acta Crystallographica Section E (2001) 57, 5 o399-o401
a=9.127(2)Å b=10.450(3)Å c=14.632(3)Å
α=99.172(19)° β=101.131(17)° γ=101.239(18)°
4-(4-Methoxyphenyl)-3-phenyl-2,4,8,10-tetraazaspiro[5.4]dec-1-ene-6,8,10-trione acetone solvate monohydrate
C19H16N4O4,C3H6O,H2O
Acta Crystallographica Section E (2005) 61, 1 o139-o141
a=6.1539(10)Å b=10.7908(17)Å c=34.057(6)Å
α=90° β=94.504(14)° γ=90°
3-Bromo-1,4-diphenyl-1,2,7,9-tetraazaspiro[5.4]dec-2-ene-6,8,10-trione acetone solvate
C18H13BrN4O3,C2H6O
Acta Crystallographica Section E (2005) 61, 1 o142-o144
a=12.027(4)Å b=13.380(5)Å c=13.416(3)Å
α=71.32(3)° β=86.159(13)° γ=87.84(3)°
7,11-Dihydro-9,10-dimethoxy-3,11b-diphenyl[1,2,4]oxadiazolo[5,4-a][2,3] benzodiazepin-6(5H)-one
C24H21N3O4
Acta Crystallographica Section C (1999) 55, 4 685-687
a=9.308(2)Å b=10.6395(19)Å c=11.225(2)Å
α=86.959(16)° β=70.753(19)° γ=79.375(18)°
C15H13N3
C15H13N3
Acta Crystallographica Section C (1998) 54, 3 405-407
a=7.0890(10)Å b=9.648(2)Å c=9.7980(10)Å
α=94.120(10)° β=108.040(10)° γ=101.22(2)°
(6,7-Dimethyl-2,3-bis(2-pyridyl)-quinoxaline-N,N')-dichloro-palladium(II) hydrate
[PdCl2(C20H16N4)],H2O
Acta Crystallographica Section C (1998) 54, 4 485-487
a=9.7495(9)Å b=13.0024(14)Å c=16.358(2)Å
α=90.00° β=94.096(8)° γ=90.00°
4-(5'-oxo-3'-phenylpyrazonyl)-3-phenylpyrazol-5-ones
C46H38N4O2
Acta Crystallographica Section C (1996) 52, 12 3129-3131
a=9.420(1)Å b=20.130(3)Å c=18.887(3)Å
α=90.° β=95.10(1)° γ=90.°
2-[1-(4-Fluorophenyl)ethyl]isonicotino-κN-hydrazide—–Cyanoborane
C15H16BFN4O
Acta Crystallographica Section C (1998) 54, 7 1038-1040
a=7.049(2)Å b=7.492(4)Å c=15.077(6)Å
α=91.57(4)° β=92.83(3)° γ=99.74(3)°
1-(3,5-Ditrifluoromethylphenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C17H10F6N2S
Acta Crystallographica Section C (1996) 52, 10 2533-2535
a=8.281(2)Å b=20.914(4)Å c=9.549(2)Å
α=90.00° β=97.46(2)° γ=90.00°
1-Fluoromethyl-1-methyl-1H,3H-thiazolo[3,4-a]benzimidazole
C11H11FN2S
Acta Crystallographica Section C (1996) 52, 10 2531-2533
a=8.127(1)Å b=6.985(1)Å c=9.306(2)Å
α=90.00° β=97.20(1)° γ=90.00°
1-(2-Fluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H11FN2S
Acta Crystallographica Section C (1997) 53, 6 764-767
a=11.3440(10)Å b=7.4370(10)Å c=15.542(2)Å
α=90.00° β=108.390(10)° γ=90.00°
1-(3-Fluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H11FN2S
Acta Crystallographica Section C (1997) 53, 6 764-767
a=11.2490(10)Å b=7.4210(10)Å c=15.867(2)Å
α=90.00° β=107.560(10)° γ=90.00°
1-(2,4-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H10F2N2S
Acta Crystallographica Section C (1997) 53, 9 1337-1341
a=11.507(2)Å b=7.3990(10)Å c=15.802(2)Å
α=90.00° β=106.830(10)° γ=90.00°
1-(2,6-dichlorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H10Cl2N2S
Acta Crystallographica Section C (1997) 53, 9 1337-1341
a=7.740(2)Å b=13.030(5)Å c=14.694(5)Å
α=83.30(3)° β=79.20(3)° γ=76.72(3)°
1-(2-chloro-6-fluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H10ClFN2S
Acta Crystallographica Section C (1997) 53, 9 1337-1341
a=22.093(5)Å b=7.8780(10)Å c=31.473(5)Å
α=90.00° β=100.28(3)° γ=90.00°
<i>N</i>,<i>N</i>'-Diisopentyldithiooxamide
C12H24N2S2
Acta Crystallographica Section E (2007) 63, 8 o3595-o3596
a=4.7658(9)Å b=6.0323(9)Å c=14.470(2)Å
α=83.082(14)° β=85.919(15)° γ=70.427(15)°
2-aminotherephtalic acid chlorohydrate and hydrate
C8H8NO4,Cl,H2O
Acta Crystallographica Section C (2006) 62, 10 o587-o589
a=6.5170(10)Å b=16.670(3)Å c=9.560(2)Å
α=90° β=108.69(2)° γ=90°
7-chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H9ClF2N2S
Acta Crystallographica Section C (2001) 57, 5 572-574
a=10.292(2)Å b=5.7410(10)Å c=23.474(4)Å
α=90.00° β=95.050(10)° γ=90.00°
1-(2,6-Difluorophenyl)-6-methyl-1H,3H-thiazolo[3,4-a]benzimidazole
C16H12F2N2S
Acta Crystallographica Section C (2001) 57, 5 572-574
a=7.6160(10)Å b=10.202(3)Å c=10.868(2)Å
α=108.86(2)° β=106.960(10)° γ=105.46(2)°
N,N,N',N'-Tetramethyldiammonium--succinate--succinic acid (1/1/1)
C6H18N22,C4H6O42,C4H4O4
Acta Crystallographica Section C (2004) 60, 4 o287-o289
a=5.6370(4)Å b=8.7100(8)Å c=8.8431(6)Å
α=96.219(7)° β=93.414(6)° γ=97.604(7)°
2,6-bis(2-pyridylthiomethyl)pyridine
C17H15N3S2
Acta Crystallographica Section C (2010) 66, 1 o15-o19
a=10.6960(10)Å b=9.2810(10)Å c=16.7410(10)Å
α=90° β=110.39(2)° γ=90°
2,6-bis(6-methyl-2-pyridylthiomethyl)pyridine
C19H19N3S2
Acta Crystallographica Section C (2010) 66, 1 o15-o19
a=7.9460(10)Å b=9.8420(10)Å c=12.5030(10)Å
α=69.829(2)° β=75.053(2)° γ=80.807(2)°
2,6-bis(4-methyl-2-pyrimidylthiomethyl)pyridine n-pentane hemisolvate
C17H17N5S2,0.5C5H12
Acta Crystallographica Section C (2010) 66, 1 o15-o19
a=7.4070(10)Å b=11.1000(10)Å c=12.4280(10)Å
α=95.910(10)° β=99.800(10)° γ=97.310(10)°
(2,2'-dipyridyl sulfide-N,N')hydroxybis(nitrito-O)(nitrosyl-O)ruthenium(II)
C10H9N5O6RuS
Acta Crystallographica Section C (2000) 56, 3 282-283
a=23.802(4)Å b=8.9550(10)Å c=13.820(2)Å
α=90.00° β=97.550(10)° γ=90.00°
N,N'-dibenzyldithioxamide
C16H16N2S2
Acta Crystallographica Section C (2002) 58, 10 o608-o609
a=7.665(2)Å b=10.533(2)Å c=9.263(2)Å
α=90° β=98.57(2)° γ=90°
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-one
C16H12N2O3
Acta Crystallographica Section C (2003) 59, 3 o117-o119
a=10.638(2)Å b=17.857(4)Å c=6.9580(10)Å
α=90° β=91.42(3)° γ=90°
Bis(di-2-pyridyl sulfide-κ^2^N,N)(4-methylpyrimidin-2-yl 2-pyridylmethyl sulfide-κ^2^N,S)ruthenium(II) bis(hexafluorophosphate) acetonitrile solvate
C31H27N7RuS3,2F6P,C2H3N
Acta Crystallographica Section C (2005) 61, 4 m169-m172
a=23.685(5)Å b=14.183(2)Å c=25.264(8)Å
α=90° β=108.941(16)° γ=90°
(+-)-3-benzoyl-1,2-dimethyl-8a-phenyl-2-benzothieno[2,3-b]pyrrole- 1,2-dicarboxylic anhydride
C27H21NO4S
Acta Crystallographica Section C (2005) 61, 10 o610-o612
a=8.6245(7)Å b=11.6423(10)Å c=13.1778(11)Å
α=97.658(3)° β=104.134(3)° γ=110.821(3)°
(4-Dimethylamino-benzylidene)-(3,5-bis(2-Pyridyl)-1,2,4-triazol-4-yl)amine
C21H19N7
Acta Crystallographica Section C (2003) 59, 7 o390-o391
a=26.300(4)Å b=9.469(2)Å c=17.440(2)Å
α=90° β=117.690(10)° γ=90°
5-Benzoylamino-3-bromo-4-(4-methoxy-phenyl)-4,5-dihydro-isoxazole- 5-carboxylic acid
C18H15BrN2O5
Acta Crystallographica Section C (2004) 60, 7 o496-o497
a=9.9280(8)Å b=19.9509(17)Å c=9.5841(14)Å
α=90° β=107.875(9)° γ=90°
Trans-bis(acetonitrile)-bis(di-2-pyridylsulfide-N,N')-ruthenium(ii) bis(tetrafluoroborate) monohydrate
C24H22N6RuS22,2(BF41),H2O
Acta Crystallographica Section C (2002) 58, 1 m56-m58
a=10.0709(7)Å b=12.6595(8)Å c=13.5470(10)Å
α=77.016(7)° β=75.004(6)° γ=68.225(6)°
3-Phenylfuro[3,2-c]chromen-4-one
C17H10O3
Acta Crystallographica Section C (2001) 57, 4 493-494
a=13.4239(11)Å b=7.2198(5)Å c=25.441(3)Å
α=90.00° β=90.00° γ=90.00°
(n-butyldiphenylphosphine)dichloro(η^6^-p-cymeme)ruthenium(II)
C26H33Cl2PRu
Acta Crystallographica Section C (2000) 56, 10 e429-e429
a=10.574(3)Å b=12.983(4)Å c=19.239(6)Å
α=90.00° β=103.99(2)° γ=90.00°
(E)-5-[(4-Nitrophenylhydrazono)phenylacetyl]-3-phenylisoxazole
C23H16N4O4
Acta Crystallographica Section C (2000) 56, 2 254-255
a=5.7870(10)Å b=29.089(3)Å c=11.8810(10)Å
α=90.00° β=100.490(10)° γ=90.00°
Ortho dimethoxybenzo-phenyldiazotropone
C17H16N2O3
Acta Crystallographica Section C (2001) 57, 10 1225-1227
a=8.207(2)Å b=10.312(2)Å c=17.236(2)Å
α=90° β=95.600(10)° γ=90°
(η^3^-Allyl-2κ^3^C)(chloro-1κCl)(μ-N,N-diethyldithioxamidato- 1:2κ^4^S,S':N,N')[diphenyl(2-pyridyl)phosphine-1κP]palladium(II)platinum(II) chloroform solvate
C26H29ClN3PPdPtS2,CHCl3
Acta Crystallographica Section C (2002) 58, 5 m316-m318
a=13.423(3)Å b=13.561(3)Å c=19.156(4)Å
α=90° β=106.83(3)° γ=90°
3-Bromo-1,9-diphenyl-4-p-tolyl-7-oxa-1,2,8-triazaspiro[4.4]nona-2,8-dien-6-one
C24H18BrN3O2
Acta Crystallographica Section C (2004) 60, 12 o879-o883
a=14.180(2)Å b=16.076(2)Å c=18.413(2)Å
α=90° β=90° γ=90°
3-Bromo-1,9-diphenyl-4-(4-methoxy-phenyl)-7-oxa-1,2,8-triazaspiro[4.4]nona- 2,8-dien-6-one
C24H18BrN3O3
Acta Crystallographica Section C (2004) 60, 12 o879-o883
a=35.375(3)Å b=9.2000(10)Å c=12.807(2)Å
α=90° β=94.810(10)° γ=90°
3-bromo-4-(4-chlorophenyl)-1,7,9-triphenyl-1,2,7,8-tetraazaspiro[4.4]nona- 2,8-dien-6-one
C29H20BrClN4O
Acta Crystallographica Section C (2004) 60, 12 o879-o883
a=16.7350(10)Å b=21.454(2)Å c=14.2540(10)Å
α=90° β=100.498(6)° γ=90°
3-Bromo-1,7,9-triphenyl-4-p-tolyl-1,2,7,8-tetraazaspiro[4.4]nona-2,8-dien-6-one
C30H22.89Br1.11N4O
Acta Crystallographica Section C (2004) 60, 12 o879-o883
a=10.1070(10)Å b=13.578(3)Å c=19.146(3)Å
α=90° β=98.500(10)° γ=90°
<i>catena</i>-Poly[[[μ-aqua-pentaaquadizinc(II)]- μ~4~-benzene-1,2,4,5-tetracarboxylato- 1:2:1:2'κ^6^O^1^,O^1'^:O^1'^:O^4^:^O^4^,O^4'^] dihydrate]
C10H14O14Zn2,2(H2O)
Acta Crystallographica Section E (2009) 65, 8 m915-m916
a=6.84290(10)Å b=8.01670(10)Å c=16.6700(2)Å
α=101.6200(10)° β=92.5550(10)° γ=93.4390(10)°
Ni(btec)(H2O)2
2(C5H7N2),C10H10NiO122,2(H2O)
Acta Crystallographica Section E (2009) 65, 10 m1203-m1204
a=7.21150(10)Å b=9.34700(10)Å c=10.6322(2)Å
α=112.7200(10)° β=108.8300(10)° γ=95.5820(10)°
<i>N</i>-(3,9-dimethyl-4-phenyl-2,5-dioxo-3,4-dihydro- 2<i>H</i>,5<i>H</i>-pyrano[3,2-<i>c</i>]chromen-3-yl)-<i>N</i>-methylbenzamide methanol monosolvate
C28H23NO5,CH4O
Acta Crystallographica Section E (2010) 66, 12 o3356
a=10.7435(14)Å b=9.9056(17)Å c=23.298(3)Å
α=90° β=94.817(7)° γ=90°
3-[2-(1<i>H</i>-1,3-benzodiazol-2-yl)ethyl]-1,3-oxazolidin-2-one
C12H13N3O2
Acta Crystallographica Section E (2011) 67, 5 o1083
a=6.0940(2)Å b=18.1570(6)Å c=10.0740(3)Å
α=90° β=90.6960(10)° γ=90°
(<i>S</i>)-2-[(2-Hydroxybenzyl)azaniumyl]-4-(methylsulfanyl)butanoate
C12H17NO3S
Acta Crystallographica Section E (2011) 67, 6 o1366-o1367
a=5.3221(2)Å b=5.8369(2)Å c=10.5564(5)Å
α=98.200(3)° β=90.780(3)° γ=96.849(3)°
31-Benzyloxy-5,11,17,23,29-penta-<i>tert</i>-butylcalix[5]arene- 32,33,34,35-tetraol
C62H76O5
Acta Crystallographica Section E (2012) 68, 12 o3423
a=14.1467(8)Å b=14.3235(9)Å c=15.2179(9)Å
α=70.653(3)° β=78.776(3)° γ=71.573(3)°
Tetrakis(μ-4-chlorobenzoato-κ^2^<i>O</i>:<i>O</i>)bis[(ethanol-κ<i>O</i>)copper(II)](<i>Cu</i>—–-<i>Cu</i>)
C32H28Cl4Cu2O10
Acta Crystallographica Section E (2013) 69, 4 m221
a=6.57660(10)Å b=11.1792(2)Å c=12.4355(3)Å
α=93.1750(10)° β=103.8900(10)° γ=98.6880(10)°